Jennifer L.  Taubert net worth and biography

Jennifer Taubert Biography and Net Worth

Jennifer Taubert is Executive Vice President and Worldwide Chairman, Pharmaceuticals at Johnson & Johnson, the world’s largest healthcare company. She is a member of the Corporation’s Executive Committee and leads the Pharmaceuticals Group Operating Committee.

Jennifer has been a leader in shaping the global strategy of transformational medical innovation for the Janssen Pharmaceutical Companies of Johnson & Johnson, successfully delivering vital new medicines for millions of people living with cancer, immune-related diseases, heart disease, pulmonary hypertension, infectious diseases and serious mental illness. Under her leadership, Janssen has become the second-largest innovative pharmaceutical business globally, with more than $50 billion in worldwide revenue. In addition, the company has been named No. 1 in the Pharmaceutical category on Fortune magazine’s “World’s Most Admired Companies” list for nine consecutive years.

Throughout her career, Jennifer has been committed to improving the lives of people with serious illnesses. Since joining Johnson & Johnson in 2005, her focus has been on reaching increasing numbers of patients around the world with the Company’s transformational therapies. Jennifer led global commercial strategy for the Pharmaceuticals Group and, later, as President, Internal Medicine, built a powerhouse new franchise in cardiovascular and metabolic disease. As Company Group Chairman, The Americas, the business doubled in size, outpacing the industry to become the No. 1 pharmaceutical company in the United States and Canada. Before joining Johnson & Johnson, Jennifer spent 17 years in positions of increasing scope and responsibility at Merck and Allergan.

In recognition of her impact on behalf of patients, Jennifer has been named to Fortune’s “Most Powerful Women” list for the past seven years. She was also named among the “100 Most Influential People in Healthcare” by Modern Healthcare magazine in 2020 and received the National Association for Female Executives’ 2017 “Woman of Achievement” award. Jennifer is also recognized as a leader in diversity, equity and inclusion, which she sees as critical to insight, innovation and business success.

Jennifer is a member of the Board of Directors of the Pharmaceutical Research and Manufacturers of America, which represents the country’s leading innovative biopharmaceutical research companies, and she is Chair of the International Committee. She also serves on the National Academy of Medicine’s Leadership Consortium and on the Advisory Board of the Leonard D. Schaeffer Center for Health Policy and Economics at the University of Southern California. In addition, Jennifer is a member of the Board of Directors of McDonald’s Corporation.

Jennifer received a bachelor’s degree in Pharmacology from the University of California, Santa Barbara and a Master of Business Administration from the Anderson Graduate School of Management, University of California, Los Angeles.

What is Jennifer L. Taubert's net worth?

The estimated net worth of Jennifer L. Taubert is at least $20.43 million as of February 9th, 2024. Ms. Taubert owns 141,416 shares of Johnson & Johnson stock worth more than $20,426,127 as of May 29th. This net worth approximation does not reflect any other assets that Ms. Taubert may own. Additionally, Ms. Taubert receives an annual salary of $3,100,000.00 as EVP at Johnson & Johnson. Learn More about Jennifer L. Taubert's net worth.

How old is Jennifer L. Taubert?

Ms. Taubert is currently 60 years old. There are 6 older executives and no younger executives at Johnson & Johnson. The oldest executive at Johnson & Johnson is Dr. John C. Reed M.D., Ph.D., Executive Vice President of Innovative Medicine, R&D, who is 66 years old. Learn More on Jennifer L. Taubert's age.

What is Jennifer L. Taubert's salary?

As the EVP of Johnson & Johnson, Ms. Taubert earns $3,100,000.00 per year. There are 2 executives that earn more than Ms. Taubert. The highest earning executive at Johnson & Johnson is Dr. John C. Reed M.D., Ph.D., Executive Vice President of Innovative Medicine, R&D, who commands a salary of $8,570,000.00 per year. Learn More on Jennifer L. Taubert's salary.

How do I contact Jennifer L. Taubert?

The corporate mailing address for Ms. Taubert and other Johnson & Johnson executives is ONE JOHNSON & JOHNSON PLZ, NEW BRUNSWICK NJ, 08933. Johnson & Johnson can also be reached via phone at (732) 524-0400 and via email at [email protected]. Learn More on Jennifer L. Taubert's contact information.

Has Jennifer L. Taubert been buying or selling shares of Johnson & Johnson?

Jennifer L. Taubert has not been actively trading shares of Johnson & Johnson within the last three months. Most recently, Jennifer L. Taubert sold 59,397 shares of the business's stock in a transaction on Friday, February 9th. The shares were sold at an average price of $156.27, for a transaction totalling $9,281,969.19. Following the completion of the sale, the executive vice president now directly owns 141,416 shares of the company's stock, valued at $22,099,078.32. Learn More on Jennifer L. Taubert's trading history.

Who are Johnson & Johnson's active insiders?

Johnson & Johnson's insider roster includes Dominic Caruso (VP), Robert Decker (CAO), Joaquin Duato (CEO & Director ), Peter Fasolo (VP), Alex Gorsky (CEO), William Hait (Insider), Ronald Kapusta (CAO), Ashley McEvoy (EVP), Thibaut Mongon (VP), William Perez (Director), Michael Sneed (COO), Paulus Stoffels (VP), James Swanson (Insider), Jennifer Taubert (EVP), Kathryn Wengel (EVP), Joseph Wolk (CFO), and Joseph Wolk (Exec. VP & CFO ). Learn More on Johnson & Johnson's active insiders.

Are insiders buying or selling shares of Johnson & Johnson?

During the last year, insiders at the sold shares 5 times. They sold a total of 110,285 shares worth more than $17,306,967.44. The most recent insider tranaction occured on February, 16th when Major Shareholder & Johnson Johnson sold 3,725 shares worth more than $96,142.25. Insiders at Johnson & Johnson own 0.2% of the company. Learn More about insider trades at Johnson & Johnson.

Information on this page was last updated on 2/16/2024.

Jennifer L. Taubert Insider Trading History at Johnson & Johnson

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
2/9/2024Sell59,397$156.27$9,281,969.19141,416View SEC Filing Icon  
11/22/2022Sell76,923$176.78$13,598,447.94126,456View SEC Filing Icon  
See Full Table

Jennifer L. Taubert Buying and Selling Activity at Johnson & Johnson

This chart shows Jennifer L Taubert's buying and selling at Johnson & Johnson by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Johnson & Johnson Company Overview

Johnson & Johnson logo
Johnson & Johnson, together with its subsidiaries, researches, develops, manufactures, and sells various products in the healthcare field worldwide. The company's Innovative Medicine segment offers products for various therapeutic areas, such as immunology, including rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; infectious diseases comprising HIV/AIDS; neuroscience, consisting of mood disorders, neurodegenerative disorders, and schizophrenia; oncology, such as prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; cardiovascular and metabolism, including thrombosis, diabetes, and macular degeneration; and pulmonary hypertension comprising pulmonary arterial hypertension through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. Its MedTech segment provides Interventional Solutions, including electrophysiology products to treat heart rhythm disorders; the heart recovery portfolio, which includes technologies to treat severe coronary artery disease requiring high-risk PCI or AMI cardiogenic shock; and neurovascular care that treats hemorrhagic and ischemic stroke. this segment also offers an orthopaedics portfolio that includes products and enabling technologies that support hips, knees, trauma, spine, sports, and other; surgery portfolios comprising advanced and general surgery technologies, as well as solutions for breast aesthetics, ear, nose, and throat procedures; contact lenses under the ACUVUE Brand; and TECNIS intraocular lenses for cataract surgery. It distributes its products to wholesalers, hospitals, and retailers, as well as physicians, nurses, hospitals, eye care professionals, and clinics. Johnson & Johnson was founded in 1886 and is based in New Brunswick, New Jersey.
Read More

Today's Range

Now: $144.45
Low: $143.72
High: $145.42

50 Day Range

MA: $150.65
Low: $144.40
High: $158.19

2 Week Range

Now: $144.45
Low: $143.13
High: $175.97

Volume

8,262,698 shs

Average Volume

7,416,246 shs

Market Capitalization

$347.64 billion

P/E Ratio

9.01

Dividend Yield

3.37%

Beta

0.55